Opinion

Video

Looking Beyond Type 2 Inflammation in Atopic Dermatitis

Author(s):

Christopher G. Bunick, MD, PhD,Lindsay S. Ackerman, MD, FAAD

Focusing on the complex pathophysiology of atopic dermatitis, Lindsay S. Ackerman, MD, FAAD, discusses the importance of looking beyond type 2 inflammation while treating patients.

Video content above is prompted by the following:

  • With better understanding of the pathophysiology of atopic dermatitis, how important is to look beyond type 2 inflammation?
Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Discussing 140-Week Data on Upadacitinib for Atopic Dermatitis, with Raj Chovatiya, MD, PhD
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Related Content
Peanut-Sensitized Infants with Eczema Already Co-Sensitized to Tree Nuts
November 20th 2024

Peanut-Sensitized Infants with Eczema Already Co-Sensitized to Tree Nuts

Tim Smith
Advances in Pediatric Eczema Highlight 2022
December 21st 2022

Advances in Pediatric Eczema Highlight 2022

Kevin Kunzmann
Gyanprakash Ketwaroo, MD, Yale and West Haven VA
November 12th 2024

AI-Assisted Colonoscopy: New Research and Guidelines for Clinical Use

Rachel Martin
How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care
July 12th 2022

How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care

Armand Butera
Ellen Sher, MD | Credit: Allergy Partners
November 11th 2024

Ellen Sher, MD: Cross-Specialty Collaboration Can Improve Atopic Dermatitis Management

Ellen Sher, MD Patrick Campbell
MJH Life Sciences logo over a white background. | Credit: MJH Life Sciences
November 11th 2024

MJH Life Sciences Celebrates Acquisition of Revolutionizing Atopic Dermatitis (RAD) Annual Meeting

Patrick Campbell
© 2024 MJH Life Sciences

All rights reserved.